Related Experiment Video
Updated: Jul 3, 2026
05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Cataract phacoemulsification and intraocular pressure in glaucoma patients
Andrzej Mierzejewski1, Iwona Eliks, Bartłomiej Kałuzny
1Department of Ophthalmology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
Klinika Oczna
|August 2, 2008
Summary
Cataract surgery (phacoemulsification) in glaucoma patients significantly lowers intraocular pressure (IOP) long-term. This reduction in IOP may allow for simplified or discontinued glaucoma medication dosages.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Cataract Surgery Outcomes
Background:
- Glaucoma management often involves controlling intraocular pressure (IOP).
- Cataract phacoemulsification is a common surgical procedure.
- The impact of phacoemulsification on IOP in eyes with pre-existing glaucoma requires evaluation.
Purpose of the Study:
- To assess the effect of cataract phacoemulsification on postoperative intraocular pressure (IOP) in patients with glaucoma.
- To analyze IOP changes in open-angle and angle-closure glaucoma patients post-surgery.
- To investigate the influence of pseudoexfoliation syndrome on IOP response to phacoemulsification.
Main Methods:
- Retrospective analysis of 100 eyes from 86 glaucoma patients undergoing cataract phacoemulsification and intraocular lens implantation.
- Patients categorized into open-angle glaucoma (71 eyes) and angle-closure glaucoma (29 eyes) groups.
- Subgroup analysis based on the presence or absence of pseudoexfoliation (PEX) syndrome.
- Intraocular pressure (IOP) measurements taken pre-surgery, one day post-surgery, and 6-30 months post-surgery.
Main Results:
- Mean preoperative IOP was 19.02 mmHg (Group I) and 20.01 mmHg (Group II).
- Postoperative IOP significantly decreased at long-term follow-up: 14.59 mmHg (Group I) and 14.01 mmHg (Group II).
- Average IOP reduction was 4.43 mmHg (Group I, P < 1x10^-5) and 6.00 mmHg (Group II, P < 1x10^-4), with greater reduction in PEX patients. Glaucoma medication needs decreased by 0.28-0.31 doses.
Conclusions:
- Phacoemulsification in glaucomatous eyes leads to a sustained reduction in intraocular pressure (IOP).
- This IOP lowering effect can simplify or eliminate the need for long-term glaucoma medications.
- Cataract surgery offers a potential therapeutic benefit for managing IOP in glaucoma patients.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...